From new board members at Houston Exponential to startups receiving funding, here are the latest short stories of Houston innovation. Photo by Zview/Getty Images

Houston's innovation ecosystem has been booming with news, and it's likely some might have fallen through the cracks.

For this roundup of short stories within Houston innovation, a startup snags funding from a new corporate venture group, a blockchain startup gets major kudos, CTV's latest investment, and more.

HX names newest board members

HX has five more members of its board. Photo courtesy

Houston Exponential has announced five new members to its governing board. Joining the group is:

  • Stephanie Campbell, managing director of the Houston Angel Network and general partner at The Artemis Fund
  • Martha Castex-Tatum, Houston City Council member
  • Gordon Daugherty, co-founder and president of Capital Factory
  • Emily Keeton, CFO of Mercato and co-founder of Station Houston
  • Roberto Moctezuma, founder and CEO of Fractal River
The board is chaired by Barbara Burger of Chevron and Chevron Technology Ventures. She will continue on as chair until the end of next year, when Blair Garrou of Mercury Fund will take over.

New corporate venture fund makes first investment

Houston-based SmartAC emerged from stealth mode this summer. Photo courtesy of smartac.com

Pinnacle Ventures, a corporate venture fund created by Pinnacle based just outside of Houston in Pasadena, announced the company has invested in Houston-based SmartAC.com, a member-based technology platform that monitors the health of air conditioning systems.

The deal is Pinnacle Ventures' first investment and will help SmartAC.com expand their service offerings to homeowners and top-level HVAC service providers.

"We are excited to have Pinnacle Ventures invest in our company and to have Ryan Sitton, founder and CEO of Pinnacle, join our board," says Josh Teekell, founder and CEO of SmartAC.com, in a news release. "The capital provided by Pinnacle Ventures will help us accelerate the growth required to meet our customer demand, which has scaled quickly since our launch in June.

"Additionally, this capital will help us power a new residential connected service economy for a $30 billion industry while offering our service partners a way to increase loyalty through improved transparency and customer experience," Teekell continues. "We're very much aligned with Pinnacle Ventures' focus on improving reliability through innovation and are confident that this investment will help us support our end users."

Data Gumbo recognized as an innovative blockchain company

CB Insights ranked 50 blockchain companies and one Houston startup made the cut. Photo via CB Insights

CB Insights released its inaugural Blockchain 50 ranking and named Houston-based Data Gumbo among the top blockchain companies in the world.

"The Blockchain 50, which we've created in conjunction with Blockdata, was born out of a desire to reduce that uncertainty and recognize the pioneering companies using the blockchain," says CB Insights CEO Anand Sanwal in the study. "This inaugural class of the Blockchain 50 is tackling a range of use cases across trade finance, capital markets, exchanges and more and are being used by banks, governments and major retailers."

Combined, the 50 companies included in the ranking have raised over $3 billion across 113 deals since 2017.

"Being named to this CB Insights' list is an honor and testament to the power of Data Gumbo's blockchain network GumboNet," says Andrew Bruce, CEO and Founder, of Data Gumbo in a news release. "Our smart contracts enable companies to leverage blockchain technology across the global business infrastructure to capture critical cost savings and value, forging a new foundation for commercial transactions: one based on trust, transparency, speed and visibility."

Currux Vision is deploying its technology in California

The Houston company's technology has been tested in California. Photo via currux.vision

Houston-based Currux Vision, which uses infra-tech artificial intelligence and machine learning solutions for smart city infrastructure, has conducted testing with the city of San Jose, California, and its department of transportation.

According to the tests, Currux Vision's SmartCity ITS can operate at 99 percent accuracy in the city. Moreover, Currux Vision can achieve high resolution results with older legacy digital and analog camera systems that offer lower resolution. Testing included but was not limited to vehicle detection and classification, turning movement counts, pedestrian counts, bicycle discrimination, stopped vehicles, and speeding, according to a press release.

"Increasing urbanization, traffic, mode shift, and increasing focus on safety drive the urgent need for a next-generation traffic management solution like our SmartCity ITS," says Alex Colosivschi, founder and CEO of Currux Vision, in the release. "We believe that efficient mobility and being able to do more with less creates economic opportunities, enables trade, improves quality of life, and facilitates access to markets and services effectively leveraging resources. ... We are happy to have worked with a great partner like San José's Department of Transportation to prove these transportation solutions."

Chevron Technology Ventures invests in software company

Chevron Technology Ventures, led by Barbara Burger, has announced its latest investment. Courtesy of CTV

Houston-based Chevron Technology Ventures has invested in a Denver-based container platform company's latest round. Nubix today announced it has closed $2.7 million in seed financing led by Tuscan Management with strategic investment from Chevron Technology Ventures, in addition to participation from other new investors.

"Businesses worldwide are investing in digital transformation initiatives with IoT-based solutions," says Rachel Taylor, Nubix co-founder and CEO, in a news release. "Our unique innovation in container and services technology enables unprecedented agility and safety when building, deploying and managing applications at the edge.

"We're delivering on digital transformation's requirements for agile compute at the edge, empowering organizations to analyze data in real-time where the data is actually created. This is a massive market opportunity for Nubix and we look forward to working hand-in-hand with our new investors as we drive agility and intelligence to the edge."

Golden Section Ventures invests in Austin startup

GSV has invested in Accelerist's impact-driven software. Image via accelerist.com

Austin-based Accelerist Inc. raised a $1 million investment round led by Houston-based Golden Section Ventures to catalyze the company's growth plans. Accelerist specializes in social impact partnership technology that nonprofits use to prospect, screen, access and measure the efficacy of their relationships with each other.

"We are very impressed with what Brittany (Hill, CEO and founder) and her team have built and are excited to join the journey," says Dougal Cameron, General Partner at GSV. "We are confident that Accelerist can be the standard of excellence for social impact partnership technology. This solution is more needed than ever."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”